Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Cytokinetics grants stock options and RSUs to new employees as inducements under Nasdaq rules.

Company Fundamentals
18 May 2026
Na
View Source
Neutral
pluang ai news

Cytokinetics granted stock options for 20,807 shares and 13,793 restricted stock units (RSUs) to eight new employees who started in April and May 2026. The RSUs vest over three years, while the stock options vest over four years with an exercise price set at $75.85 per share, matching the closing price on May 15, 2026. These grants are inducements to employment under Nasdaq Listing Rule 5635(c)(4). Cytokinetics is a biopharmaceutical company focused on cardiac muscle diseases, advancing treatments like MYQORZO® and other investigational drugs.

More News (CYTK)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App